课题基金 / 基金详情

PET tracer for imaging senescence

PET tracer for imaging senescence
用于衰老成像的 PET 示踪剂
批准号:
10727823
负责人:
Jianghong Rao
金额:
$23.33万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-07-10 至 2025-06-30
关键词:
3-DimensionalAddressAgingAnimal Cancer ModelAnimal ModelAutophagocytosisBiochemicalBiologicalBrain DiseasesCASP3 geneCancer ModelCell AgingCell Culture TechniquesCell CycleCell Cycle ArrestCell ProliferationCellsChelating AgentsChemotherapy-Oncologic ProcedureChromogenic SubstratesColonic NeoplasmsComplexDNA DamageDegenerative polyarthritisDevelopmentDiabetes MellitusDiseaseDoxorubicinEnzyme KineticsEnzymesFibrosisFluorineFucosidaseFutureGadoliniumHCT116 CellsHomeostasisHumanHydrolaseHydrolysisImageImmune systemImmunofluorescence ImmunologicImmunologic SurveillanceIn SituIn VitroInflammationKidney DiseasesLabelMacrophageMagnetic Resonance ImagingMalignant NeoplasmsMessenger RNAMetabolicMetabolic DiseasesMethodsModelingMonosaccharidesOncogene ActivationOncogenesOpticsOsteoclastsOxidative StressPenetrationPeptide HydrolasesPermeabilityPhenotypePhotonsPositron-Emission TomographyProliferation MarkerReportingResearchRoleSecretory CellSensitivity and SpecificitySignal TransductionSignaling MoleculeSpecificitySpidersStressTelomere ShorteningTissue StainsTissuesTracerTranslationsTumor SuppressionValidationWestern BlottingWorkbeta-Galactosidasebeta-galactosidecancer imagingcell typecellular imagingchemotherapydesignenzyme activityhealingimaging detectionimaging modalityimaging platformimaging probeimprovedin vitro Assayin vivoin vivo imaginginterestmeeting abstractsmouse modelnanoassemblynon-invasive imagingnoveloptical imagingprematurerational designresearch and developmentretention ratesenescencesingle photon emission computed tomographysmall moleculestressortargeted treatmenttumortumor xenograftuptake

项目摘要

项目成果

Jianghong Rao的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY / ABSTRACT Senescence is a state of permanent cell cycle arrest, and can occur during development (programmed senescence), or be triggered by a variety of stressors, like telomere shortening (defined as replicative senescence), oxidative stress DNA damage, and oncogene activation (stress-induced premature senescence). Senescent cells remain metabolically active and secrete high concentrations of signaling molecules into the tissue microenvironment (known as Senescence-Associated Secretory Phenotype, or SASP). These secreted factors can activate immune systems to initiate clearance of senescent cells, which contribute to tumor suppression, would healing and tissue homeostasis. When the immunosurveillance fails to eliminate senescent cells, their accumulation causes inflammation and contributes to a variety of diseases, including cancer, metabolic disorders, fibrosis, diabetes, brain disorders, osteoarthritis, and kidney disease. These complex and important roles in ageing and diseases prompt extensive interest in developing imaging methods to detect senescence cells. A number of optical imaging probes have been developed by targeting senescence-associated beta-galactosidase (SA-b-gal) activity. However, their use in vivo is limited due to poor penetration and scattering photons in living tissues. Several SPECT, MRI, and PET probes have been reported to address this limitation, but they displayed either poor cell permeability and/or sensitivity. In the case of PET tracers, they generally suffer from a lack of efficient signal retention mechanism. This research proposes to develop a novel PET tracer for in vivo imaging of senescence in a mouse model of cancer by targeting a novel lysosomal enzyme and using an in celluo probe assembly retention strategy. There are two Specific Aims: 1) synthesize the PET tracer and assess its capacity to detecting senescence in cell culture; 2) validate the PET tracer in animal models of therapy induced senescence. This project would provide a more specific and sensitive PET tracer for imaging cell senescence in vivo and for future translation into human studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting apoptotic cells to enhance radiotherapy
  • 批准号:
    10708827
  • 项目类别:
  • 资助金额:
    $55.95万
  • 财政年份:
    2022
  • 负责人:
    Jianghong Rao
  • 依托单位:
Targeting apoptotic cells to enhance radiotherapy
  • 批准号:
    10538071
  • 项目类别:
  • 资助金额:
    $57.42万
  • 财政年份:
    2022
  • 负责人:
    Jianghong Rao
  • 依托单位:
Copper-depleting nanotheranostics for treating triple negative breast cancer
  • 批准号:
    10004020
  • 项目类别:
  • 资助金额:
    $53.56万
  • 财政年份:
    2019
  • 负责人:
    Jianghong Rao
  • 依托单位:
Copper-depleting nanotheranostics for treating triple negative breast cancer
  • 批准号:
    10231101
  • 项目类别:
  • 资助金额:
    $53.56万
  • 财政年份:
    2019
  • 负责人:
    Jianghong Rao
  • 依托单位:
海外基金